While its safety profile was consistently favorable, the largest Phase IIb trial failed to show statistical significance for weight loss, and commercial development was halted in 2007.[2] Despite this, interest in AOD-9604 has continued in the compounding pharmacy and integrative medicine space, particularly given its safety data, its lack of IGF-1 stimulation, and emerging research around joint health
Product Format & Classification This compound is offered in a research format intended for educational and laboratory contexts
Peptides are short chains of amino acids that function as your body's natural communication system, carrying specific instructions between cells about healing, repair, and regeneration
It also plays a role in certain behaviors
KPV An anti-inflammatory peptide studied for gut barrier integrity, with potential applications in inflammatory bowel conditions
Together these nutrients may support energy, metabolism, and fat breakdown as part of a comprehensive wellness program